MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2026-03-31.

Cash Flow Overview

Free Cash flow
-$45,487K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of inve...
    • Stock-based compensation
    • Depreciation and amortization of...
    • Others
Negative Cash Flow Breakdown
    • Purchases of investments
    • Accounts payable and accrued exp...
    • Prepaid expenses and other asset...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
Net loss
-47,594 -42,538 -180,585
Depreciation and amortization of property and equipment
1,608 1,678 7,193
Amortization of finance lease right of use asset
538 539 1,615
Impairment of operating lease right-of-use asset
-262 -
Stock-based compensation
8,493 6,112 30,947
Accretion of discount on investments, net
1,020 1,088 5,886
Change in fair value of warrant liabilities
-0 0
Prepaid expenses and other assets
1,643 -1,150 -939
Accounts payable and accrued expenses
-5,749 -967 -9,384
Operating lease liabilities and right of use assets, net
-29 11 34
Finance lease liability
0 2 33
Other liabilities
2 -1 -80
Net cash used in operating activities
-45,394 -34,840 -155,174
Purchases of investments
48,709 54,495 222,058
Proceeds from maturities of investments
66,250 91,000 289,760
Purchases of property and equipment
93 80 360
Net cash provided by (used in) investing activities
17,448 36,425 67,342
Issuance of common stock, net of issuance costs-Public Offering
-0 -
Issuance of common stock pursuant to exercise of stock options
-0 0
Return of related party short-swing profits
-0 215
Repurchase of restricted stock units to satisfy tax withholding
-0 67
Finance lease liability
1 --
Net cash used in financing activities
-1 0 148
Net change in cash, cash equivalents and restricted cash
-27,947 1,585 -87,684
Cash, cash equivalents and restricted cash at beginning of period
78,898 77,313 164,997
Cash, cash equivalents and restricted cash at end of period
50,951 78,898 77,313
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof investments$66,250K Net cash provided by(used in) investing...$17,448K Canceled cashflow$48,802K Net change in cash,cash equivalents and...-$27,947K Canceled cashflow$17,448K Stock-based compensation$8,493K Depreciation andamortization of property and...$1,608K Amortization of finance leaseright of use asset$538K Other liabilities$2K Purchases of investments$48,709K Purchases of property andequipment$93K Net cash used inoperating activities-$45,394K Canceled cashflow$10,641K Net cash used infinancing activities-$1K Net loss-$47,594K Accounts payable andaccrued expenses-$5,749K Prepaid expenses andother assets$1,643K Accretion of discount oninvestments, net$1,020K Operating leaseliabilities and right of use...-$29K Finance lease liability$1K

ROCKET PHARMACEUTICALS, INC. (RCKTW)

ROCKET PHARMACEUTICALS, INC. (RCKTW)